Brigitte Widemann Recognized for Pioneering Work on Debilitating Disease
Wednesday, August 18, 2021
Getting diagnosed with a serious illness as an adult can be devastating, so one can hardly imagine the impact of receiving such news as a child, particularly when the disease has no good treatments. Until recently, this was the case for many children with the potentially severe and frequently disfiguring condition neurofibromatosis type 1 (NF1). However, pioneering research led by IRP senior investigator Brigitte C. Widemann, M.D., led to the first-ever drug approved by the U.S. Food and Drug Administration (FDA) to treat the condition. For this groundbreaking work, Dr. Widemann, her IRP research team, and her collaborators outside NIH were named as finalists for the 2020 Samuel J. Heyman Service to America Medals, also known as the ‘Sammies,’ an award that honors exceptional work by government employees.
Tuesday, September 4, 2018
With summer winding down, it's about time we took another dive into some NIH history! These new additions to the NIH Stetten Museum collection feature some of the most prominent investigators ever to walk the NIH campus, including a Nobel prize winner and a scientist who made important discoveries about how electricity travels between neurons.
Tuesday, May 22, 2018
NIH history is rife with legends, scientists who have made remarkable discoveries and incalculable contributions to the health and longevity of humankind. There are living legends; just peruse the “Honors” page on the IRP website to see what I mean. And there are greats who are gone but certainly not forgotten.
Tuesday, November 14, 2017
Francia Fang, who is currently a junior at Duke University, spent her 2017 summer working in the lab of NIH IRP Senior Investigator Dr. Zhengping Zhuang. During her time at the NIH, Fang investigated how genes influence the development of brain tumors and also shadowed doctors as they met with brain cancer patients.
The video above, featuring Fang, is the first in a series of profiles highlighting IRP summer interns who worked in NIH National Institute of Neurological Disorders and Stroke (NINDS) intramural labs this past summer.
Friday, April 8, 2016
Like many in the second wave of women scientists at the National Institutes of Health, Dr. Margaret Kelly began as a technician and got her PhD while she was working. Kelly focused on what caused cancer and what drugs could be used to fight it.
Wednesday, October 7, 2015
The Partnership for Public Service has awarded Steven A. Rosenberg, M.D., chief of the Surgery Branch in NCI's Center for Cancer Research, with its highest 2015 Samuel J. Heyman Service to America Medal, or Sammie, for his research to develop life-saving immune-based therapies for patients with advanced cancers.
Wednesday, September 16, 2015
A panel of three genetic markers may help to identify patients with early-stage lung cancer who have a very strong likelihood of their disease returning after surgery, according to findings from a study by NCI researchers. Read more...